According to the current analysis of Reports and Data, the global Microwave Ablation Market was valued at USD 973.4 million in 2018 and is expected to reach USD 2.30 billion by year 2026, at a CAGR of 11.2 %. The study covers Microwave Ablation therapy uses some form of energy like radiofrequency, heat, electricity or cold to destroy and remove a tumor. Microwave Ablation has primarily been used for the treatment of esophageal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia. Ablation is preferred over other methods of treatment such as conventional surgery due to multiple advantages like no skin incision minimal risk to patient, little to no pain inflicted and a short duration of hospital stay. The increasing economic impact of cancer which shows increased prevalence of cancer among the population which increases the demand for the cancer treatment. In the year 2016 US the annual cost for cancer was USD 80.2 billion of which 38% cost was estimated due to inpatient hospital stays which can be reduced to quite good extent as the Microwave Ablation demands short duration of hospital stay.

Rising prevalence of target diseases such as lung and liver cancer due to various reasons such as unhealthy living styles and hereditary factor, unmet needs of patients demanding drug developments, increased focus of pharmaceutical companies on development of easier methods of testing and monitoring,  entry of various players, private investment and governmental funding, and favorable regulatory scenario, increasing demand for less to no pain treatments are some of the key factors driving the market growth in the industry. New technological innovation of surgical technology taking place such as development in existing radio frequency ablation system now with multi electrode radio frequency system which produces radiofrequency using multi channels. However, the Microwave Ablation market is hampered by slow rate of commercialization, high costs involved in research and development, reluctance toward the adoption of new treatment practices and government regulations that require long certification and approval cycles.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2029

Further key findings from the report suggest

• Microwave Ablation market is growing at a CAGR of 12% in Asia Pacific followed by North America and Europe, with 0% and 10.9% CAGR, respectively. High cancer prevalence across the globe is the major factor driving the market during the forecast period across all regions.
• The Radiofrequency Ablation segment dominates the market with a 25% market share. It is also estimated to grow at a CAGR of 10.3% as it is more preferably used for localized Microwave Ablation surgery especially for malignant liver cancer as it do not require longer period of hospital stay for the pre surgery observations
• The microwave ablation segment is forecasted to be the fastest growing market segment, estimated to hold a 12.1% CAGR. Microwave ablation expects less risk and shorter duration of the hospital stay. Microwave ablation can perform for the treatment of multiple tumors simultaneously
• Based on end use, the liver cancer segment dominates the market holding a 23.0% market share and is estimated to grow at a 12.1% CAGR. For the year 2018 American Cancer Society forecasted the liver cancer cases in the US might be approximately 42,220 and is expected to keep on increasing. It is the only cancer in the US which is continuously increasing
• Asia Pacific is expected to account for the 26.6% of the global Microwave Ablation market. Developing nations such China, and India are likely to witness high growth due to uncontrolled population growth, more aged population, adherence to unhealthy habits and diet and infinite pollution growth
• Slow rate of commercialization, high costs involved in research and development, reluctance toward the adoption of new treatment practices and government regulations that require long certification and approval cycles are likely to hamper growth of the market
• One of the major manufacturer of medical device Boston Scientific acquired BTG PLC in November of the year 2018 which will expand Boston Scientific’s product line as well as it will improve the geographical reach of the company which will boost the company’s total sales along with the US regional sales. Boston Scientific also will be increasing cancer indication regarding the product of BTG, TheraSphere radiotherapy product and ICEfx cryoablation technology.

Key Players covered in this report are

Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2029

Treatment Type Outlook (Revenue, USD Million; 2016-2026)

• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

Technology Type Outlook (Revenue, USD Million; 2016-2026)

• Radiofrequency Ablation
• Cryoablation
• Microwave Ablation
• Irreversible Electroporation
• Other Ablation Technologies

Application Type Outlook (Revenue, USD Million; 2016-2026)

• Liver Cancer
• Lung Cancer
• Breast cancer
• Prostate Cancer
• Other Cancer

Geographic Segment Covered in the Report:

The Microwave Ablation report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Microwave Ablation industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Microwave Ablation Market report provides key statistics on the market status of the Microwave Ablation manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2029

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Hematopoietic Stem Cell Transplantation (HSCT) Market @ https://www.biospace.com/article/hematopoietic-stem-cell-transplantation-hsct-market-analysis-statistics-revenue-demand-and-trend-analysis-research-report-by-2027/

Healthcare Rcm Outsourcing Market @ https://www.biospace.com/article/healthcare-rcm-outsourcing-market-size-share-top-key-players-growth-trend-and-forecast-till-2027/

Fertility Enhancing Treatment Market @ https://www.biospace.com/article/fertility-enhancing-treatment-market-trends-revenue-key-players-growth-share-and-forecast-till-2027/

Embolization Particles Market @ https://www.biospace.com/article/embolization-particles-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2027/

Cervical Interbody Fusion Cages Market @ https://www.biospace.com/article/cervical-interbody-fusion-cages-market-analysis-statistics-revenue-and-trend-analysis-research-report-by-2028/

Capecitabine Market @ https://www.biospace.com/article/capecitabine-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2028/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]